Literature DB >> 6306712

3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.

W Friedl, P Propping, B Weck.   

Abstract

Human platelets possess high-affinity 3H-imipramine binding sites. A study in ten healthy volunteers showed that platelet preparations produced by mechanical disruption contained varying proportions of intact platelets, as measured by the cytoplasmic marker enzyme LDH. This may invalidate the protein reference. Higher proportions of membranes in the preparations lead to higher Bmax values of imipramine binding (fmol/mg protein). The use of intact platelets in imipramine binding studies is therefore preferable to membrane preparations, particularly in studies where the interindividual variation of binding parameters is of interest.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306712     DOI: 10.1007/bf00427505

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  A comparison of methods for platelet lysis and the isolation of platelet membranes.

Authors:  A J Barber; D S Pepper; G A Jamieson
Journal:  Thromb Diath Haemorrh       Date:  1971-08-31

2.  Isolation and characterization of plasma membranes from human blood platelets.

Authors:  A J Barber; G A Jamieson
Journal:  J Biol Chem       Date:  1970-12-10       Impact factor: 5.157

3.  Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.

Authors:  S M Paul; M Rehavi; P Skolnick; F K Goodwin
Journal:  Life Sci       Date:  1980-03-24       Impact factor: 5.037

4.  Human platelets possess high-affinity binding sites for 3H-imipramine.

Authors:  M S Briley; R Raisman; S Z Langer
Journal:  Eur J Pharmacol       Date:  1979-10-01       Impact factor: 4.432

5.  Demonstration of specific high affinity binding sites for [3H] imipramine in human brain.

Authors:  M Rehavi; S M Paul; P Skolnick; F K Goodwin
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

6.  Specific tricyclic antidepressant binding sites in rat brain.

Authors:  R Raisman; M Briley; S Z Langer
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Human platelet imipramine recognition sites: biochemical and pharmacological characterization.

Authors:  L P Wennogle; B Beer; L R Meyerson
Journal:  Pharmacol Biochem Behav       Date:  1981-12       Impact factor: 3.533

9.  Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

Authors:  S M Paul; M Rehavi; P Skolnick; J C Ballenger; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1981-12

10.  Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients.

Authors:  M S Briley; S Z Langer; R Raisman; D Sechter; E Zarifian
Journal:  Science       Date:  1980-07-11       Impact factor: 47.728

View more
  5 in total

Review 1.  Platelet research in psychiatry.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1988-02-15

2.  Genetic control of adrenergic receptors on human platelets. A twin study.

Authors:  P Propping; W Friedl
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

3.  3H-clonidine and 3H-yohimbine binding to glass fiber filters: implications for studies with platelet membranes.

Authors:  J E Piletz; A C Andorn; A Halaris
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  3H-imipramine and 3H-cyano-imipramine binding in rat brain tissue: effect of long-term antidepressant administration.

Authors:  C Gentsch; M Lichtsteiner; H Feer
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

5.  Neuroleptics and beta-carbolines displace (3H)Imipramine from its binding sites in human and rat tissues.

Authors:  H Rommelspacher; S Strauss
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.